المؤلفون: E. Yu. Zlatnik, A. B. Sagakyants, L. Yu. Vladimirova, A. V. Tishina

المصدر: Медицинская иммунология, Vol 26, Iss 4, Pp 835-842 (2024)

مصطلحات موضوعية: cytokines, chemokines, multiplex analysis, colorectal cancer, kras mutation, monoclonal antibodies for treatment, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://www.mimmun.ru/mimmun/article/view/3057; https://doaj.org/toc/1563-0625; https://doaj.org/toc/2313-741X

URL الوصول: https://doaj.org/article/67efbeb59b78490896e4fbc457fd6cce

المؤلفون: Alessandra Raimondi, Vincenzo Adamo, Roberto Murialdo, Patrizia Racca, Filippo de Braud, Monica Niger, Valeria Smiroldo, Marco Tampellini, Fausto Petrelli, Monica Giordano, Chiara Cremolini, Alberto Zaniboni, Saverio Cinieri, Matteo Clavarezza, Federica Morano, Alfredo Falcone, Marta Caporale, Rosa Berenato, Vittorina Zagonel, Salvatore Corallo, Francesca Bergamo, Filippo Pietrantonio, Andrea Sartore-Bianchi, Maria Di Bartolomeo, Gianluca Tomasello, Rosalba Miceli, Maria Antista, Sara Lonardi, Raffaella Longarini, Lorenza Rimassa

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Intermittent, Cetuximab, Chemotherapy Plus, Gastroenterology, law.invention, 03 medical and health sciences, 0302 clinical medicine, Maintenance therapy, Randomized controlled trial, Interquartile range, law, Internal medicine, medicine, Clinical endpoint, Panitumumab, 030212 general & internal medicine, EGFR Monoclonal-Antibodies, 1ST-line Treatment, Chemotherapy Plus, Non-Inferiority, Open-Label, Cetuximab, Bevacizumab, Oxaliplatin, Kras, Intermittent, business.industry, Non-Inferiority, medicine.disease, 1ST-line Treatment, Bevacizumab, Oxaliplatin, Regimen, Oncology, Fluorouracil, 030220 oncology & carcinogenesis, EGFR Monoclonal-Antibodies, Kras, Open-Label, business, Progressive disease, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeb9fd0d9893386f50df6c7cda317d22
http://hdl.handle.net/11570/3169569

المؤلفون: Massimo Milione, Alessandra Raimondi, Federica Palermo, Annunziata Gloghini, Vincenzo Adamo, Roberto Murialdo, Andrea Sartore-Bianchi, Giovanni Fucà, Adele Busico, Patrizia Racca, Sara Lonardi, Chiara Cremolini, Antonia Martinetti, Matteo Clavarezza, Lorenza Rimassa, Federica Morano, Filippo Pietrantonio, Filippo de Braud, Federica Perrone, Fotios Loupakis, Salvatore Corallo, Maria Di Bartolomeo, Gianluca Tomasello, Alberto Zaniboni, Elena Tamborini

المصدر: Journal of Clinical Oncology

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Organoplatinum Compounds, Colorectal cancer, Leucovorin, Maintenance Chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Growth factor receptor, Maintenance therapy, Internal medicine, Gastrointestinal Cancer, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Panitumumab, Humans, Neoplasm Metastasis, Aged, Retrospective Studies, Monoclonal-Antibodies, 1ST-line treatment, Plus Cetuximab, Open Label, Survival, Fluorourascil, Chemotherapy, Bevacizumab, Leucovorn, Irinotecan, business.industry, Patient Selection, Wild type, Retrospective cohort study, ORIGINAL REPORTS, Middle Aged, medicine.disease, Primary tumor, Clinical trial, Oxaliplatin, 030104 developmental biology, 030220 oncology & carcinogenesis, Colonic Neoplasms, ras Proteins, Female, Fluorouracil, business, Colorectal Neoplasms, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c517561f3166e4dd92057be13881151a
http://hdl.handle.net/11568/1021588